| Bioactivity | GB2095 is a selective, orally active inhibitor for galectin-3 with Kd of 36 nM and 0.35 μM for human galectin-3 and mouse galectin-3. GB2095 exhibits antitumor efficacy in mouse models[1]. |
| Target | Kd: 36 nM (human galectin-3); 0.35 μM (mouse galectin-3) |
| Formula | C20H17BrClF2N3O4S |
| Molar Mass | 548.79 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Peterson K, et al., Development and Characterization of a High-Affinity Selective Galectin-3 Mouse Tool Compound in Mouse Models of Cancer. J Med Chem. 2024 Dec 26;67(24):21905-21915. |